Reynolds, Kerry
499  results:
Search for persons X
?
1

Cancer type and histology influence cutaneous immunotherapy..:

Wan, Guihong ; Khattab, Sara ; Leung, Bonnie W...
British Journal of Dermatology.  191 (2024)  1 - p. 117-124 , 2024
 
?
2

Pilot Trial of an Educational Immunotherapy Intervention fo..:

Petrillo, Laura ; Hsu, Kelly E. ; Pintro, Kedie...
Journal of Pain and Symptom Management.  67 (2024)  5 - p. e575 , 2024
 
?
4

Pre-existing inflammatory disease predicts cutaneous immuno..:

Wan, Guihong ; Nguyen, Nga ; Leung, Bonnie W....
Journal of the American Academy of Dermatology.  90 (2024)  2 - p. 418-420 , 2024
 
?
6

Tofacitinib is Effective in Treating Refractory Immune Chec..:

Wang, Mike ; Reynolds, Kerry L. ; Montazeri, Kamaneh...
Clinical Gastroenterology and Hepatology.  22 (2024)  7 - p. 1539-1541.e2 , 2024
 
?
8

Influence of melanoma type on incidence and downstream impl..:

Nguyen, Nga ; Wan, Guihong ; Ugwu-Dike, Pearl...
Journal of the American Academy of Dermatology.  88 (2023)  6 - p. 1308-1316 , 2023
 
?
9

Noncutaneous immune-related adverse events predict overall ..:

Asdourian, Maria S. ; Jacoby, Ted V. ; Shah, Nishi...
Journal of the American Academy of Dermatology.  88 (2023)  6 - p. 1368-1370 , 2023
 
?
10

Soluble and cell-based markers of immune checkpoint inhibit..:

Sise, Meghan E ; Wang, Qiyu ; Seethapathy, Harish...
Journal for ImmunoTherapy of Cancer.  11 (2023)  1 - p. e006222 , 2023
 
?
11

Low-grade cutaneous immune-related adverse events leading t..:

Jacoby, Ted V. ; Asdourian, Maria S. ; Shah, Nishi...
Clinical and Experimental Dermatology.  48 (2023)  9 - p. 1058-1060 , 2023
 
?
13

Dermatology evaluation for cutaneous immune-related adverse..:

Jacoby, Ted V. ; Shah, Nishi ; Asdourian, Maria S....
Journal of the American Academy of Dermatology.  88 (2023)  3 - p. 711-714 , 2023
 
?
14

Tumor-infiltrating lymphocytes as a predictive biomarker of..:

Stephens, Michael R. ; Asdourian, Maria S. ; Jacoby, Ted V....
Journal of the American Academy of Dermatology.  89 (2023)  1 - p. 140-142 , 2023
 
1-15